Free Trial

Talis Biomedical (TLIS) Short Interest Ratio & Short Volume

Talis Biomedical logo
$1.40 -0.03 (-2.10%)
As of 06/4/2025 11:24 AM Eastern

Talis Biomedical Short Interest Data

Talis Biomedical (TLIS) has a short interest of 5,400 shares. This marks a 0.00% change in short interest from the previous month. The short interest ratio (days to cover) is 18.0, indicating that it would take 18.0 days of the average trading volume of 2,736 shares to cover all short positions.

Current Short Interest
5,400 shares
Previous Short Interest
5,400 shares
Change Vs. Previous Month
No Change
Dollar Volume Sold Short
$7,614.00
Short Interest Ratio
18.0 Days to Cover
Last Record Date
May 15, 2025
Outstanding Shares
1,823,000 shares
Percentage of Shares Shorted
0.30%
Today's Trading Volume
203 shares
Average Trading Volume
2,736 shares
Today's Volume Vs. Average
7%
Short Selling Talis Biomedical?
cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook

Sign up to receive the latest short interest report for Talis Biomedical and its competitors with MarketBeat's FREE newsletter.

Skip Charts & View Short Interest History

TLIS Short Interest Over Time

TLIS Days to Cover Over Time

TLIS Percentage of Float Shorted Over Time

Talis Biomedical Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
5/15/20255,400 shares $7,614.00 No ChangeN/A18 $1.41
4/30/20255,400 shares $8,640.00 No ChangeN/A54 $1.60
4/15/20255,400 shares $9,180.00 No ChangeN/A2 $1.70
3/14/20255,400 shares $8,640.00 No ChangeN/A0.8 $1.60
2/14/20255,600 shares $10,640.00 No ChangeN/A14 $1.90
1/31/20255,600 shares $8,792.00 -41.1%N/A1.4 $1.57
8/31/202420,100 shares $88,038.00 +11.7%1.2%0.7 $4.38
8/15/202418,000 shares $74,520.00 -15.5%1.1%1 $4.14
7/31/202421,300 shares $184,777.50 +52.1%1.3%1.5 $8.68
7/15/202414,000 shares $118,160.00 -4.8%0.8%2.1 $8.44
6/30/202414,700 shares $127,328.46 +9.7%0.9%2 $8.66
6/15/202413,400 shares $119,394.00 No Change0.8%1.8 $8.91
5/31/202413,400 shares $123,280.00 +5.5%0.8%1.8 $9.20
5/15/202412,700 shares $113,665.00 -5.2%0.8%1.6 $8.95
4/30/202413,400 shares $115,508.00 +8.9%0.8%1.5 $8.62
4/15/202412,300 shares $104,427.00 -7.5%0.7%1.4 $8.49
3/31/202413,300 shares $116,375.00 -4.3%0.8%1.5 $8.75
3/15/202413,900 shares $126,490.00 +6.9%0.8%1.5 $9.10
2/29/202413,000 shares $104,520.00 -8.5%0.8%1.3 $8.04
2/15/202414,200 shares $121,268.00 -22.4%0.9%1.3 $8.54
1/31/202418,300 shares $142,008.00 +7.0%1.1%1.1 $7.76
1/15/202417,100 shares $139,365.00 +18.8%1.0%1 $8.15
12/31/202314,400 shares $107,280.00 -37.7%0.9%0.9 $7.45
12/15/202323,100 shares $185,955.00 +1.8%1.4%1.4 $8.05
11/30/202322,700 shares $173,655.00 +33.5%1.4%1.5 $7.65
11/15/202317,000 shares $125,120.00 -0.6%1.0%1.2 $7.36
10/31/202317,100 shares $81,738.00 +19.6%1.0%2.5 $4.78
10/15/202314,300 shares $75,791.43 +24.4%0.9%2.2 $5.30
9/30/202311,500 shares $66,355.00 -25.8%0.7%1.1 $5.77
9/15/202315,500 shares $95,945.00 +10.7%0.9%1.2 $6.19
8/31/202314,000 shares $86,800.00 -21.8%0.8%1.1 $6.20
8/15/202317,900 shares $127,448.00 -20.8%1.1%1.2 $7.12
7/31/202322,600 shares $169,048.00 -5.8%1.4%1.5 $7.48
7/15/202324,000 shares $189,280.80 +56.9%1.5%1.7 $7.89
6/30/202315,300 shares $110,160.00 -94.1%0.9%1.3 $7.20
6/15/2023258,600 shares $116,628.60 +42.4%1.1%2.1 $0.45
5/31/2023181,600 shares $89,056.64 -27.0%0.8%1.6 $0.49
5/15/2023248,600 shares $111,870.00 -25.2%1.0%2.9 $0.45
4/30/2023332,400 shares $162,876.00 +21.4%1.4%3.9 $0.49
4/15/2023273,900 shares $127,116.99 -7.6%1.1%3 $0.46
Elon just did WHAT!? (Ad)

As you may recall, Biden and the Fed were working on a central bank digital currency, or CBDC. Had they gotten away with it, the Fed and U.S. banks could have seized control of our financial lives forever. But Trump stopped them cold on January 23rd, 2025, when he outlawed CBDCs… Paving the way for Elon Musk's secret master plan.

Click here to see how to claim your stake before they launch to avoid missing out.
3/31/2023296,300 shares $145,187.00 +6.0%1.2%3.4 $0.49
3/15/2023279,500 shares $156,799.50 +10.7%1.2%2.4 $0.56
2/28/2023252,400 shares $146,392.00 -10.6%1.1%2.2 $0.58
2/15/2023282,200 shares $172,508.86 +25.3%1.2%2.5 $0.61
1/31/2023225,300 shares $141,510.70 -4.1%0.9%2.1 $0.63
1/15/2023234,800 shares $135,362.20 -9.7%1.0%2.1 $0.58
12/30/2022260,000 shares $115,882.00 +10.5%1.1%2.1 $0.45
12/15/2022235,300 shares $128,709.10 +3.4%1.0%2.2 $0.55
11/30/2022227,600 shares $124,884.12 -1.0%1.0%2 $0.55
11/15/2022230,000 shares $115,046.00 -28.3%1.0%1.8 $0.50
10/31/2022320,900 shares $213,430.59 +13.0%1.3%1.5 $0.67
10/15/2022283,900 shares $196,118.12 +1.1%1.2%1.3 $0.69
9/30/2022280,800 shares $191,393.28 +14.3%1.2%1.4 $0.68
9/15/2022245,600 shares $219,222.56 -0.4%1.0%1.1 $0.89
8/31/2022246,500 shares $221,850.00 -19.3%1.0%1.1 $0.90
8/15/2022305,400 shares $264,262.62 +14.9%1.3%1.3 $0.87
7/31/2022265,900 shares $210,061.00 -10.2%1.1%1.6 $0.79
7/15/2022296,200 shares $258,878.80 -13.8%1.2%1.7 $0.87
6/30/2022343,700 shares $279,084.40 -57.3%1.4%1.9 $0.81
6/15/2022804,300 shares $770,438.97 +0.7%3.3%4.4 $0.96
5/31/2022798,500 shares $838,425.00 +11.9%3.3%4.3 $1.05
5/15/2022713,300 shares $699,034.00 +1.2%3.0%4.2 $0.98
4/30/2022705,100 shares $740,355.00 +27.5%2.9%4.7 $1.05
4/15/2022553,000 shares $707,840.00 +0.6%2.3%4 $1.28
3/31/2022549,700 shares $775,077.00 +9.0%2.3%4 $1.41
3/15/2022504,300 shares $852,267.00 -0.9%2.1%3.4 $1.69
2/28/2022508,900 shares $1.06 million +8.8%2.1%3.8 $2.09
2/15/2022467,900 shares $1.02 million -10.6%2.0%3 $2.18
1/31/2022523,300 shares $1.54 million -4.3%2.3%2.7 $2.95
1/15/2022546,900 shares $1.78 million -28.5%2.5%2.9 $3.26
12/31/2021764,700 shares $3.07 million -16.9%3.4%3.9 $4.01
12/15/2021919,700 shares $3.72 million +33.1%4.1%4.7 $4.04
11/30/2021691,200 shares $3.23 million -63.8%3.1%3.5 $4.68
11/15/20211,910,000 shares $11.08 million +11.1%8.6%9.9 $5.80
10/29/20211,720,000 shares $9.20 million +11.7%7.9%7.8 $5.35
10/15/20211,540,000 shares $8.81 million +10.8%7.1%6.6 $5.72
9/30/20211,390,000 shares $8.69 million +8.6%6.4%4.2 $6.25
9/15/20211,280,000 shares $9.60 million -4.5%5.9%3.7 $7.50
8/31/20211,340,000 shares $10.80 million -19.3%6.2%3.6 $8.06
8/13/20211,660,000 shares $12.85 million No Change7.6%4.6 $7.74

TLIS Short Interest - Frequently Asked Questions

What is Talis Biomedical's current short interest?

Short interest is the volume of Talis Biomedical shares that have been sold short but have not yet been closed out or covered. As of May 15th, traders have sold 5,400 shares of TLIS short. Learn More on Talis Biomedical's current short interest.

What is a good short interest ratio for Talis Biomedical?

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. TLIS shares currently have a short interest ratio of 18.0. Learn More on Talis Biomedical's short interest ratio.

How does Talis Biomedical's short interest compare to its competitors?

Here is how the short interest of companies in the industry of "measuring and control equipment" compare to Talis Biomedical: Astrotech Co. (0.08%), Accelerate Diagnostics, Inc. (1.94%), Telesis Bio, Inc. (1.02%), Schmitt Industries, Inc. (0.00%), ThermoGenesis Holdings, Inc. (0.00%), HTG Molecular Diagnostics, Inc. (0.07%), Trane Technologies plc (1.56%), Keysight Technologies, Inc. (1.38%), Veralto Co. (1.47%), Fortive Co. (2.22%),

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: Invesco QQQ ($29.20 billion), Strategy Incorporated ($10.88 billion), iShares 20+ Year Treasury Bond ETF ($10.04 billion), Capital One Financial Co. ($5.51 billion), Charter Communications, Inc. ($5.00 billion), Super Micro Computer, Inc. ($4.43 billion), Apollo Global Management, Inc. ($4.02 billion), Hims & Hers Health, Inc. ($3.65 billion), VanEck Semiconductor ETF ($3.27 billion), and Coinbase Global, Inc. ($3.10 billion). View all of the most shorted stocks.

What does it mean to sell short Talis Biomedical stock?

Short selling TLIS is an investing strategy that aims to generate trading profit from Talis Biomedical as its price is falling. TLIS shares are trading down $0.03 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against Talis Biomedical?

A short squeeze for Talis Biomedical occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of TLIS, which in turn drives the price of the stock up even further.

How often is Talis Biomedical's short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including TLIS, twice per month. The most recent reporting period available is May, 15 2025.




This page (NASDAQ:TLIS) was last updated on 6/6/2025 by MarketBeat.com Staff
From Our Partners